Tag: Department of Health and Social Care

The press release issued by the Department of Health and Social Care, on 31 August 2022.

Based on UKHSA advice, the UK Chief Medical Officers and NHS England National Medical Director have recommended to Ministers the COVID Alert Level moves from Level 3 to Level 2.

Hospitals and the wider health systems remain extremely busy overall but the summer BA.4 and BA.5 wave is subsiding and direct COVID severe illness is now a much smaller proportion of this. Severe COVID cases, direct COVID healthcare pressures, direct COVID deaths and ONS community positivity estimates have decreased. COVID remains present in the community and we may see an increase in cases with BA 4.6 and BA.2.75 circulating but do not expect this to lead to an immediate increase in hospital pressures. This will continue to be kept under review. Further COVID surges are likely so please be prepared by getting a vaccination when it is offered.

Chief Medical Officer for England, Professor Sir Chris Whitty
Chief Medical Officer for Northern Ireland, Professor Sir Michael McBride
Chief Medical Officer for Scotland, Professor Sir Gregor Smith
Deputy Chief Medical Officer for Wales, Professor Chris Jones
NHS England National Medical Director, Professor Sir Stephen Powis.

Health and Social Care Secretary Steve Barclay and ministers from the devolved administrations have accepted the advice.

Background

The Covid alert levels are as follows:

level 1: COVID-19 is present in UK, but the number of cases and transmission is low
level 2: COVID-19 is in general circulation but direct COVID-19 healthcare pressures and transmission are declining or stable
level 3: a COVID-19 epidemic is in general circulation
level 4: a COVID-19 epidemic is in general circulation; transmission is high and direct COVID-19 pressure on healthcare services is widespread and substantial or rising
level 5: as level 4 and there is a material risk of healthcare services being directly overwhelmed by COVID-19

The press release issued by the Department for Health and Social Care on 31 August 2022.

• Minister of State for Health Maria Caulfield signs the arrangement with Guernsey’s Chief Minister in central London
• People planning to travel to Guernsey next year are encouraged to take their UK Global Health Insurance Card which is being expanded and improved post Brexit

UK residents visiting the Bailiwick of Guernsey will benefit from free necessary healthcare, and vice versa, after a landmark deal was signed today (Wednesday 31st August).

The reciprocal healthcare arrangement – which comes into force on 1st January 2023 – will mean UK residents can access emergency and necessary healthcare services for free in Guernsey, Alderney, Sark, or Herm, when on a temporary visit lasting up to six months.

Attendance at Accident and Emergency and urgent GP appointments will be included in the new arrangement, while those with a pre-existing condition will be able to receive necessary treatment, like kidney dialysis or chemotherapy, if this is arranged and agreed prior to travel. Small charges may apply for services that people routinely pay for in the UK, such as prescriptions.

The UK’s new reciprocal healthcare eligibility card – the Global Health Insurance Card (GHIC) – will be the main eligibility document used to access healthcare in Guernsey. Those planning to travel to Guernsey, Alderney, Sark, or Herm next year are being encouraged to take their GHIC with them.

Around 200,000 UK residents visit the Bailiwick of Guernsey each year, and they are currently individually liable for the full cost of medically necessary or emergency care while visiting the territory.

Minister of State for Health Maria Caulfield said:

“Post Brexit we are focussed on delivering deals which mean UK travellers can use their GHIC in more places, including in the Bailiwick of Guernsey where UK visitors will receive free healthcare should they need it during their visit.

None of us can plan for unexpected medical emergencies, and I want to encourage anyone planning to travel to Guernsey next year to take their GHIC so they get all the benefits of this deal.

This arrangement will help both residents of the UK and those across the Bailiwick of Guernsey, and is testament to the strength and close cooperation across the British family.”

Residents from the Bailiwick of Guernsey will also be able to access necessary healthcare when visiting England, Scotland, Wales, and Northern Ireland on the same basis as someone living in the UK.

Health authorities from the Bailiwick will also be able to refer patients to the NHS for pre-authorised treatment at cost, allowing them to source vital and urgent healthcare not available locally.

Chief Minister of Guernsey, Deputy Peter Ferbrache said:

“I’m very pleased to have today signed a new reciprocal health arrangement with the UK on behalf of the Bailiwick of Guernsey. It has been a priority for our community for some years, due to the social and economic links between the UK and the Islands of Guernsey, Alderney, Sark and Herm.

When it comes into effect early next year it will benefit both island residents and visitors from the UK, making travel easier whether it’s for leisure, business or to see family and friends.”

Following our departure from the European Union, the UK is now negotiating reciprocal healthcare arrangements with countries outside of the EU. This includes expanding the GHIC to countries outside of the European Economic Area and Switzerland, like the Bailiwick of Guernsey.

The GHIC was introduced to gradually replace European Health Insurance Cards (EHIC), and gives UK residents’ rights to emergency and medically necessary healthcare in multiple territories, including across the whole of the European Union and Switzerland

The GHIC is free to obtain from the official GHIC website. People should apply at least 2 weeks before they plan to travel to ensure their card arrives on time. Those with an existing EHIC can use it up to expiry, and should someone forget either card alternative arrangements can be made.

The government is still advising people travelling abroad to take out travel insurance which includes medical cover. This is because the GHIC may not provide cover for all events, like medical repatriation back to the UK, ski or mountain rescue, or for any treatment in a private facility.

The press release issued by the Department of Health and Social Care on 30 August 2022.

• Recommendations are to be taken forward by Department of Health and Social Care to help ensure continued HRT supply meets demand
• Forms part of wider work to support menopausal women access the health and care they need and tackle the gender health gap

Action will be taken to make supplies of hormone replacement therapy (HRT) more resilient as Head of the HRT Taskforce Madelaine McTernan presents her key recommendations to support future management of the supply chain.

The recommendations will inform the work of the department and the UK wide menopause taskforce as Ms McTernan has returned to working full time as the Director General of the Vaccine Taskforce as preparation for the autumn booster campaign ramps up.

Improving access to HRT forms part of the government’s wider commitment to tackle the gender health gap, including support for menopausal women. The Women’s Health Strategy, published earlier this year, includes the menopause as a key area.

Access to HRT has improved following decisive actions to increase supply and manage demand including issuing Serious Shortage Protocols on HRT products to limit dispensing to three months’ supply and allow specified alternative products to be supplied if necessary.

Following positive engagement across the supply chain, suppliers have also moved to secure additional stock and expedite deliveries of HRT products experiencing supply issues. Suppliers are building future capacity to support continued growth in demand.

These combined actions have resulted in improvement in supply of products including Oestrogel gel. The number of packs of Oestrogel delivered to the UK in July was double the monthly average for the first quarter this year demonstrating a very substantial increase.

Health and Social Care Secretary Steve Barclay said:

Women’s health is a priority for this government, and we are ensuring everyone who needs HRT is able to access it.

Madelaine’s work and that of her taskforce and the department has been vital, and her recommendations will ensure progress in HRT supply continues.

Core recommendations from the HRT taskforce include:

• Continued dialogue with industry both via continuing the successful model of regular industry roundtables as well as individual engagement
• Continued use of Serious Shortage Protocols when appropriate to manage shortages as steps are taken by suppliers to increase production
• Continued assessment whether NHS formularies may be impacting access to HRT

Taking steps to action these recommendations 12 of the 13 Serious Shortage Protocols (SSPs) in place for HRT have been extended to help provide ongoing stability as HRT products that have experienced supply issues increase stock levels. The department has also established quarterly industry roundtables with key suppliers to ensure continued dialogue and help industry to plan for the future.

Outgoing Head of the HRT Taskforce Madelaine McTernan said:

I am pleased to see the situation with HRT supply is improving across the country. I want to thank suppliers and manufacturers for their engagement and positive action to tackle this serious issue.

I have presented my key learnings on how the department can continue to manage HRT supply and work with the industry as it continues efforts to meet rising demand.

Further recommendations to help ensure continued HRT supply to meet rising demand:

• Improved access to data on prescriptions to more easily see where there are shortfalls between HRT packs prescribed and HRT packs supplied by manufacturers; and
• Taking lessons from the HRT supply chain work to inform broader medicine supply work

Minister for Women’s Health Maria Caulfield said:

We are taking steps across the board to tackle the gender health gap and ensure women can access the health and care services they need – including access to HRT.

I thank Madelaine and her team and I look forward to taking forward her recommendations as part of the ongoing work of the department.

The taskforce has held two roundtables and has ongoing discussions with key suppliers to understand issues and engage on plans to meet demand.

It has issued Serious Shortage Protocols (SSPs) to restrict dispensing of certain products to three months and allow pharmacists to substitute certain products for alternatives.

Following a return to good availability, Premique Low Dose is no longer subject to an SSP.  The MHRA, have delivered workshops to ensure manufacturers and pharmacists are aware of guidance to help them manage stock levels and worked with the NHS to understand and communicate the role of formularies (a list of recommended medicines) in terms of access to HRT.

Government has also taken action to reduce costs of HRT. The creation of a prepayment certificate will mean women can access HRT on a month-by-month basis if needed, easing pressure on supply, paying a one-off charge equivalent to two single prescription charges (currently £18.70) for all their HRT prescriptions for a year. This system will be implemented by April 2023.

The Menopause Taskforce, which meets every two months, will continue to tackle issues surrounding the menopause including increasing access to treatment, and ending the taboos and stigmas that still surround conversations about the menopause, including in the workplace.

Dame Lesley Regan has also been appointed the first ever Women’s Health Ambassador for England to support in the implementation of the Women’s Health Strategy and improve women’s experiences of the health and care system in England.

The press release issued by the Department of Health and Social Care on 28 August 2022.

• The extension would make it easier for skilled professionals returning to the NHS to deliver high-quality care to patients
• Move would help to bolster the workforce ahead of winter so the they can continue to bust the Covid backlogs

Retired and partially retired NHS staff could have important NHS pension changes extended to make it easier for them to return to the workforce or to continue supporting the health system over winter, as the government launches a new consultation today.

Ahead of what could be a challenging winter where we expect more people to come forward for checks, these measures will help support and boost the workforce. In this way, we are putting in place preparations that will put the health system in the strongest possible position to tackle the pressures and bust the Covid backlogs.

Since March 2020, certain retire and return rules in the pension scheme have been suspended to allow retired staff to return to work or increase their working commitments without having the payment of their pension benefits suspended.

The measures are currently set to run until 31 October 2022 and the consultation will gather views from the public and stakeholders on whether to extend the measures to 31 March 2023.

This would allow skilled and experienced staff and have stepped up to support the system to continue working for the NHS throughout the potentially challenging upcoming winter period, easing pressures on the system and helping to tackle the Covid backlogs.

Health and Social Care Secretary Steve Barclay said:

“The country is hugely thankful to all the retired staff who returned to support the NHS and the public during the pandemic.

This winter will be challenging too and we are putting in place the necessary preparations to support the NHS while it continues to deliver first-rate care to patients.

As part of this we are now consulting on extending temporary changes to the NHS pension scheme, which have so far allowed highly-skilled retired staff to return to the workforce without having their pension benefits affected.”

The NHS pension scheme is one of the best available, providing generous retirement benefits for hardworking staff after a lifetime of service looking after the nation’s health.

The government is committed to growing and supporting the NHS workforce, with over 4,100 more doctors and 9,600 more nurses compared to last year, and remains on track to deliver on the manifesto commitment to have 50,000 more nurses by 2024, with 29,000 more nurses already. The government has also commissioned NHS England to develop a long term workforce plan to recruit and support staff while they deliver high-quality, safe care to patients.

To prepare for winter, the government is working closely with the NHS at pace to prepare for the pressures ahead, including by increasing capacity, boosting NHS 111 and 999 support with at least 4,800 staff working in 111 and 2,500 in 999 call rooms to meet high demand, tackling delayed discharge and using new innovations such as virtual wards by creating the equivalent of at least 7,000 more beds.

The Secretary of State for Health and Social Care and NHS England recently set out plans to address winter pressures. He has also launched a taskforce to drive up the recruitment of international staff into critical roles across the system, alongside recruiting and retaining more doctors and nurses, so staff can continue their work of busting the Covid backlogs, having now virtually eliminated waits of over two years as part of the Elective Recovery Plan – backed by record investment.

The press release issued by the Department of Health and Social Care on 28 August 2022.

NHS pension scheme changes could be extended to allow retired staff to retain pension benefits if they return to the workforce.

• The extension would make it easier for skilled professionals returning to the NHS to deliver high-quality care to patients
• Move would help to bolster the workforce ahead of winter so they can continue to bust the Covid backlogs

Retired and partially retired NHS staff could have important NHS pension changes extended to make it easier for them to return to the workforce or to continue supporting the health system over winter, as the government launches a new consultation today (Sunday 28 August 2022).

Ahead of what could be a challenging winter where we expect more people to come forward for checks, these measures will help support and boost the workforce. In this way, we are putting in place preparations that will put the health system in the strongest possible position to tackle the pressures and bust the Covid backlogs.

Since March 2020, certain retire and return rules in the pension scheme have been suspended to allow retired staff to return to work or increase their working commitments without having the payment of their pension benefits suspended.

The measures are currently set to run until 31 October 2022 and the consultation will gather views from the public and stakeholders on whether to extend the measures to 31 March 2023.

This would allow skilled and experienced staff that have stepped up to support the system to continue working for the NHS throughout the potentially challenging upcoming winter period, easing pressures on the system and helping to tackle the Covid backlogs.

Health and Social Care Secretary Steve Barclay said:

“The country is hugely thankful to all the retired staff who returned to support the NHS and the public during the pandemic. This winter will be challenging too and we are putting in place the necessary preparations to support the NHS while it continues to deliver first-rate care to patients.

As part of this we are now consulting on extending temporary changes to the NHS pension scheme, which have so far allowed highly-skilled retired staff to return to the workforce without having their pension benefits affected.”

The NHS pension scheme is one of the best available, providing generous retirement benefits for hardworking staff after a lifetime of service looking after the nation’s health.

The government is committed to growing and supporting the NHS workforce, with over 4,100 more doctors and 9,600 more nurses compared to last year, and remains on track to deliver on the manifesto commitment to have 50,000 more nurses by 2024, with 29,000 more nurses already. The government has also commissioned NHS England to develop a long term workforce plan to recruit and support staff while they deliver high-quality, safe care to patients.

To prepare for winter, the government is working closely with the NHS at pace to prepare for the pressures ahead, including by increasing capacity, boosting NHS 111 and 999 support with at least 4,800 staff working in 111 and 2,500 in 999 call rooms to meet high demand, tackling delayed discharge and using new innovations such as virtual wards by creating the equivalent of at least 7,000 more beds.

The Secretary of State for Health and Social Care and NHS England recently set out plans to address winter pressures. He has also launched a taskforce to drive up the recruitment of international staff into critical roles across the system, alongside recruiting and retaining more doctors and nurses, so staff can continue their work of busting the Covid backlogs, having now virtually eliminated waits of over two years as part of the Elective Recovery Plan – backed by record investment.

Matthew Taylor, chief executive of the NHS Confederation (which includes NHS Employers), said:

“The NHS will need all of the help it can get this winter and so, we are pleased the Government will be consulting on ways to provide support to the NHS’s workforce by encouraging recent and partial retirees back to the frontline.

This is not the only action that it is needed to respond to the rising demand for healthcare services but leaders hope it will help. On behalf of our members, we look forward to providing views in the consultation.”

The press release issued by the Department of Health and Social Care on 26 August 2022.

• Over 50 new surgical hubs will provide at least 100 more operating theatres and 1,000 more beds to deliver millions more operations
• These beds and theatres will help reduce waiting times and offer patients access to vital operations
• Beds will be ring fenced for planned operations, reducing the risk of short-notice cancellations

Over 50 new surgical hubs will open across the country to help bust the Covid backlogs and offer hundreds of thousands more patients quicker access to vital procedures, the Health and Social Care Secretary Steve Barclay has announced today.

These hubs will provide at least 100 more operating theatres and over 1,000 beds so people get the surgery they need. They will deliver almost two million extra routine operations to reduce waiting lists over the next three years, backed by £1.5 billion in government funding. This breaks down to over 200,000 extra procedures in 2022-23, over 700,000 extra procedures in 2023-24, and one million extra procedures by 2024-25.

They will focus mainly on providing high volume low complexity surgery, as previously recommended by the Royal College of Surgeons of England, with particular emphasis on ophthalmology, general surgery, trauma and orthopaedics (including spinal surgery), gynaecology, ear nose and throat, and urology.

Located on existing hospital sites, surgical hubs bring together skills and expertise of staff under one roof – reducing waiting times for some of the most common procedures such as cataract surgeries and hip replacements. These operations can be performed quickly and effectively in one place. Improving quality and efficiency will mean patients have shorter waits for surgery, will be more likely to go home on the same day, and will be less likely to need additional treatment after surgery.

As the hubs are separated from emergency services, surgical beds are kept free for patients waiting for planned operations, reducing the risk of short-notice cancellations and improving infection control.

Health and Social Care Secretary Steve Barclay said:

“In order to bust the Covid backlogs and keep pace with future demands, we can’t simply have business as usual. Surgical hubs are a really tangible example of how we are already innovating and expanding capacity to fill surgical gaps right across the country, to boost the number of operations and reduce waiting times for vital procedures.

We have already made progress in tackling the longest waiting lists to offer patients quicker access to treatment, and these new surgical hubs will in their own right deliver additional operations over the next three years, including over 200,000 this year alone.”

NHS chief executive, Amanda Pritchard, said:

“Surgical hubs are a vital part of plans to recover elective services across England and these new sites will be a welcome boost in helping us to further tackle the covid-19 backlogs that have inevitably built up over the pandemic.

The NHS has made significant progress already, virtually eliminating two year waits for care by the end of July and from surgical hubs to robotic surgery, our staff continue to find innovative ways to speed up care for patients.”

The hubs will also help address variation in performance between trusts, as they are required to meet national standards on numbers of operations, the full use of theatre facilities, and ensuring patients are discharged on the same day as their operation. All of this will help to drive up performance across the country.

The government has worked with the NHS to identify which areas will benefit most from surgical hubs. The selection process for surgical hub locations is clinically led and aims to ensure the new hubs are connected to the right local services – such as acute hospital sites – and tackle local healthcare inequalities while promoting the best outcomes for patients and delivering value for taxpayers.

So far, locations for 20 new or expanded hubs have already been confirmed, and bids for the remaining hubs are set to be considered over the coming weeks and months as more business cases are received to determine the new sites meet design standards.

The new hubs will offer a mix of outpatient and admitted (including overnight or day case) surgeries, delivering nearly two million additional procedures over the next three years, equal to 12% of all elective activity in 2019/20. They will encourage the most efficient forms of surgeries, ensuring that fewer patients are kept overnight and saving more time to carry out additional operations.

Currently, 91 surgical hubs have already been opened, meaning that in total more than 140 hubs will be open across England by 2024/25. This includes:

• The South West London Elective Orthopaedic Centre contains five state-of-the-art operating theatres and accepts patients from all over the UK. It performs approximately 5,200 procedures a year, 3,000 of which are joint replacements.
• Another hub at the Oxford University Hospitals NHS Foundation Trust has increased surgical capacity by 25%, with improvement plans now in place to significantly reduce cancellations.
• United Lincolnshire Hospitals NHS Foundation Trust has cut down the length of stay for patients undergoing hip and knee replacements, resulting in an average reduction of two days and allowing more people to go home the day after surgery.

The government has committed £5.9 billion in capital investment to support elective recovery in the coming years. Along with surgical hubs, the NHS is changing the way diagnostic services are delivered by opening over 90 community diagnostic centres across the country in locations such as football stadiums and shopping centres.

They have already delivered over 1.6 million checks, tests and scans, offering patients a range of healthcare services closer to home. By 2025, up to 160 will be up and running.

Thanks to these innovative approaches, significant progress has already been made in tackling waiting lists. Earlier this month, the NHS announced that waits of over two years for routine treatment have been virtually eliminated, except where patients chose to wait longer, did not want to travel to be seen faster, or for very complex cases requiring specialist treatment.

This was the first target set out in the Elective Recovery Plan in February and NHS staff continue to make progress on reducing long waits – with a drop of almost one third in people waiting 18 months or more for care since January.

The press release issued by the Department of Health and Social Care on 24 August 2022.

• Routine asymptomatic testing will be paused across remaining settings, including hospitals and care homes, from 31 August as Covid cases continue to fall
• Testing for individuals with symptoms in these settings, including health and social care staff, will continue
• Immunocompromised patients in hospitals and people being admitted into care homes and hospices will also continue to be tested

Regular asymptomatic testing for Covid in all remaining settings in England will be paused from 31 August, as Covid cases continue to fall.

Free testing for the public ended on 1 April as part of the government’s Living with Covid plan, but asymptomatic testing continued to be used in some settings during periods of high case rates.

The vaccination programme means Covid cases have now fallen to 40,027 and the risk of transmission has reduced. Deaths have fallen to 744 and hospitalisations to 6,005 in the last seven days, meaning wider asymptomatic testing can soon end as planned in most instances. Symptomatic testing in high risk settings will continue.

Settings where asymptomatic testing of staff and patients or residents will be paused include:

• The NHS (including independent health care providers treating NHS patients);
• Adult social care and hospice services (apart from new admissions);
• Parts of the prison estate and some places of detention; and
• Certain domestic abuse refuges and homelessness settings.

Testing will remain in place for admissions into care homes and hospices from both hospitals and the community, and for transfers for immunocompromised patients into and within hospital to protect those who are most vulnerable.

Testing will also be available for outbreaks in certain high-risk settings such as care homes.

Year-round symptomatic testing will continue to be provided in some settings, including:

• NHS patients who require testing as part of established clinical pathways or those eligible for Covid treatments;
• NHS staff and staff in NHS-funded independent healthcare provision;
• Staff in adult social care services and hospices and residents of care homes, extra care and supported living settings and hospices;
• Staff and detainees in prisons; and
• Staff and service users of certain domestic abuse refuges and homelessness services.

Individuals will continue to be protected through vaccination and access to antivirals where eligible.

The government continues to encourage all who are eligible to take up boosters. Autumn boosters will be available to book through the National Booking Service ahead of the wider rollout, due to start on the 12 September. The NHS will contact people when it is their turn.

Health and Social Care Secretary Steve Barclay said:

“Thanks to the success of our world-leading vaccination roll-out, we are able to continue living with Covid and, from 31 August, we will pause routine asymptomatic testing in most high-risk settings.

This reflects the fact case rates have fallen and the risk of transmission has reduced, though we will continue to closely monitor the situation and work with sectors to resume testing should it be needed. Those being admitted into care homes will continue to be tested.

Our upcoming autumn booster programme will offer jabs to protect those at greatest risk from severe Covid, and I urge everyone who is eligible to take up the offer.”

Dr Susan Hopkins, Chief Medical Adviser to the UK Health Security Agency, said:

“Covid case rates and hospitalisations are on the decline, demonstrating the positive impact of the vaccines, which remain our best form of defence. The data from our surveillance shows prevalence is low and decreasing, and we will continue to monitor this data closely.

If you are invited to receive a booster jab in the autumn, or if you have not yet had a Covid vaccine, please do take up the offer to protect yourself and those around you.”

The government expects the prevalence of Covid to remain low following the most recent wave but will keep the situation under review. In line with the Living with Covid plan, the government will continue to work closely with sectors and services and will be ready to resume testing if required.

Guidance on testing in adult social care settings will be updated today (24 August) and guidance on other high-risk settings will follow shortly.

On 15 August, the Joint Committee on Vaccination and Immunisation (JCVI) published its advice on which vaccines should be used in this year’s Autumn booster programme. This includes the approval of new dual-strain (or “bivalent”) vaccines as part of the programme, targeting both the original strain of the virus and the new, more prevalent Omicron strain.

All of the available boosters provide good protection against severe illness from Covid and the Committee has emphasised that getting a booster in good time before the winter season is more important for those eligible than the type of vaccine that is received.

The press release issued by the Department of Health and Social Care on 23 August 2022.

– National safeguarding guidance to be published by Royal College of Paediatrics and Child Health for under-18s accessing early medical abortions.

– Additional data on use of remote abortions to be gathered to better understand use of remote abortion services.

Women in England and Wales will be able to permanently access early medical abortions at home from 30 August.

New legislation will allow women to access pills for early medical abortion via a teleconsultation, and for both pills to be taken at home for gestation of up to nine weeks and six days.

The update comes as all independent sector abortion clinics in England have been reapproved ensuring abortion services continue to be available to women across the country. All current approvals are valid until 31 July 2026.

Minister for Public Health, Maggie Throup, said:

“The wellbeing and safety of women requiring access to abortion services is paramount.

With these measures women will have more choice in how and where they access abortion services, while ensuring robust data is collected to ensure their continued safety.”

To ensure the continued safety of children and young people, the Royal College of Paediatrics and Child Health will publish safeguarding guidance for under-18s accessing early medical abortion services.

The guidance, which will be published shortly, reinforces the principles that every young person should have access to early medical abortions in a timely manner and that their holistic and safeguarding needs must be addressed by providers.

To effectively monitor the impact and use of at home early medical abortions, doctors will be required to include information on place of termination, place of consultation as well as whether the consultation was fully remote on abortion notification forms. This data will allow for analysis of trends in abortion provision as well as monitoring pathways for home-use abortions.

Doctors will also be required to certify in “good faith” that the gestation period is below 10 weeks for abortion pills prescribed from home and if one or both pills are taken at a woman’s home.

The amendments to the notification forms and certification requirement are set out in the Abortion (Amendment) Regulations 2022. These changes follow a free vote by Members of Parliament in March 2022.

The press release issued by the Department of Health and Social Care on 11 August 2022.

The government has launched a call for evidence to gather insights from experts and organisations on the potential racial and gender bias of medical devices.

As part of an Independent Review on Equity in Medical Devices led by Professor Dame Margaret Whitehead, the government is seeking to tackle disparities in healthcare by gathering new evidence on how medical devices and technologies may be biased against patients of different ethnicities, genders and other socio-demographic groups.

Through the call for evidence, which will be open for 8 weeks, it hopes to hear from those who work most closely with medical devices such as oxygen measuring devices and infrared scanners and related software and hardware, including databases and instructions. This applies across a device’s entire life cycle – from evaluation to marketing and implementation – to identify potential biases at each and every stage.

For example, some devices employing infrared light or imaging may not perform as well with patients with darker skin pigmentation, which has not been accounted for in the development and testing of the devices, and has led to patients being recruited with only a limited range of lighter skin tones.

The independent review, which the call for evidence will feed into, aims to reduce the potential for medical devices to worsen existing healthcare disparities, ensuring people can receive the best-possible care throughout their patient experience regardless of their ethnicity or gender.

Health Minister Gillian Keegan said:

“I am committed to ensuring all patients receive high-quality, innovative healthcare without discrimination.

The independent review is part of our vital work to tackle healthcare inequalities, and I invite the industry to share their expertise in the call for evidence so we can ensure medical devices are free of any form of bias.”

Members of expert and professional groups and organisations, including academics, researchers, engineers, healthcare professionals and industry representatives, are invited to submit evidence and insights regarding potential disparities and proposed solutions, with this evidence informing the independent review.

Members of the public, patients and carers can also contribute their views and insights on these topics.

Research suggests the way some medical devices are designed and used may be failing to account for differences related to ethnic background, gender or other characteristics such as disabilities – potentially exacerbating existing inequalities in healthcare.

While current UK regulations set out clear expectations on medical devices and technologies, they do not currently include provisions to ensure that medical devices are working equally well for different groups in the population based on their social or demographic characteristics.

The independent review will cover different types of medical devices, including devices enabled by artificial intelligence (AI) used in diagnosing illness and determining therapy pathways, as well as risk-scoring systems using genomics to make decisions about personalised medicine.

It will consider in what ways existing or future regulations could successfully address any biases in medical devices that arise at any stage of their design, development, evaluation, implementation and use.

Patients can be reassured that the NHS is expert in providing the best possible care, and the review is intended to accelerate the process of improving the quality and availability of medical devices to diverse communities.

Professor Dame Margaret Whitehead, chair of the independent review, said:

“We aim to establish where and how potential ethnic and other unfair biases may arise in the design and use of medical devices, and what can be done to make improvements.

We especially encourage health, technology and industry experts and researchers to share their views and any evidence concerning medical devices in order to help us tackle inequalities in healthcare.”

The review chair will issue the panel’s report to the Secretary of State for Health and Social Care setting out clear options for consideration by spring 2023 with interim findings expected in winter 2022.

The press release issued by the Department of Health and Social Care on 10 August 2022.